Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer

Part II: Hereditary nonpolyposis colorectal carcinoma as a model

Henry T. Lynch, Patrice Watson, Trudy G. Shaw, Jane F. Lynch, Anne E. Harty, Barbara A. Franklin, Christine R. Kapler, Susan T. Tinley, Bo Liu, Caryn Lerman

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Hereditary nonpolyposis colorectal carcinoma (HNPCC) is the most common hereditary form of colorectal carcinoma (CRC) and may account for 5-10% of the total CRC burden. The discovery of DNA mismatch repair (MMR) genes, inclusive of hMSH2, hMLH1, hPMS2, and hMSH6, has enabled the identification of who has and who does not have inordinately increased susceptibility to CRC as well as a litany of extracolonic cancers. Mutation testing has focused on hMSH2 and hMLH1, the most common mutations in HNPCC. The protocol for DNA testing and DNA-based genetic counseling is described in Part I of this study. One hundred ninety-nine bloodline relatives were tested and counseled from five hMLH1 and two hMSH2 families. Their major reason for seeking genetic counseling and DNA testing was to inform their children and other loved ones of their mutation status. Those who sought counseling overestimated their risk for inheriting the mutation and showed a high rate of interest in prophylactic surgery, and many were greatly concerned about insurance discrimination. Knowledge about HNPCC, its molecular genetic diagnosis, surveillance and management opportunities, and genetic counseling implications are still emerging, all in the face of a greater need for physician education regarding all facets of hereditary cancer.

Original languageEnglish
Pages (from-to)2457-2463
Number of pages7
JournalCancer
Volume86
Issue number11 SUPPL.
StatePublished - Dec 1 1999

Fingerprint

Genetic Counseling
Molecular Biology
Colorectal Neoplasms
Neoplasms
Mutation
DNA
DNA Mismatch Repair
Insurance
Counseling
Physicians
Education
Genes

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Lynch, H. T., Watson, P., Shaw, T. G., Lynch, J. F., Harty, A. E., Franklin, B. A., ... Lerman, C. (1999). Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: Part II: Hereditary nonpolyposis colorectal carcinoma as a model. Cancer, 86(11 SUPPL.), 2457-2463.

Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer : Part II: Hereditary nonpolyposis colorectal carcinoma as a model. / Lynch, Henry T.; Watson, Patrice; Shaw, Trudy G.; Lynch, Jane F.; Harty, Anne E.; Franklin, Barbara A.; Kapler, Christine R.; Tinley, Susan T.; Liu, Bo; Lerman, Caryn.

In: Cancer, Vol. 86, No. 11 SUPPL., 01.12.1999, p. 2457-2463.

Research output: Contribution to journalArticle

Lynch, HT, Watson, P, Shaw, TG, Lynch, JF, Harty, AE, Franklin, BA, Kapler, CR, Tinley, ST, Liu, B & Lerman, C 1999, 'Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: Part II: Hereditary nonpolyposis colorectal carcinoma as a model', Cancer, vol. 86, no. 11 SUPPL., pp. 2457-2463.
Lynch, Henry T. ; Watson, Patrice ; Shaw, Trudy G. ; Lynch, Jane F. ; Harty, Anne E. ; Franklin, Barbara A. ; Kapler, Christine R. ; Tinley, Susan T. ; Liu, Bo ; Lerman, Caryn. / Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer : Part II: Hereditary nonpolyposis colorectal carcinoma as a model. In: Cancer. 1999 ; Vol. 86, No. 11 SUPPL. pp. 2457-2463.
@article{83066ba025bb4731a6b9ead545b87295,
title = "Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer: Part II: Hereditary nonpolyposis colorectal carcinoma as a model",
abstract = "Hereditary nonpolyposis colorectal carcinoma (HNPCC) is the most common hereditary form of colorectal carcinoma (CRC) and may account for 5-10{\%} of the total CRC burden. The discovery of DNA mismatch repair (MMR) genes, inclusive of hMSH2, hMLH1, hPMS2, and hMSH6, has enabled the identification of who has and who does not have inordinately increased susceptibility to CRC as well as a litany of extracolonic cancers. Mutation testing has focused on hMSH2 and hMLH1, the most common mutations in HNPCC. The protocol for DNA testing and DNA-based genetic counseling is described in Part I of this study. One hundred ninety-nine bloodline relatives were tested and counseled from five hMLH1 and two hMSH2 families. Their major reason for seeking genetic counseling and DNA testing was to inform their children and other loved ones of their mutation status. Those who sought counseling overestimated their risk for inheriting the mutation and showed a high rate of interest in prophylactic surgery, and many were greatly concerned about insurance discrimination. Knowledge about HNPCC, its molecular genetic diagnosis, surveillance and management opportunities, and genetic counseling implications are still emerging, all in the face of a greater need for physician education regarding all facets of hereditary cancer.",
author = "Lynch, {Henry T.} and Patrice Watson and Shaw, {Trudy G.} and Lynch, {Jane F.} and Harty, {Anne E.} and Franklin, {Barbara A.} and Kapler, {Christine R.} and Tinley, {Susan T.} and Bo Liu and Caryn Lerman",
year = "1999",
month = "12",
day = "1",
language = "English",
volume = "86",
pages = "2457--2463",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "11 SUPPL.",

}

TY - JOUR

T1 - Clinical impact of molecular genetic diagnosis, genetic counseling, and management of hereditary cancer

T2 - Part II: Hereditary nonpolyposis colorectal carcinoma as a model

AU - Lynch, Henry T.

AU - Watson, Patrice

AU - Shaw, Trudy G.

AU - Lynch, Jane F.

AU - Harty, Anne E.

AU - Franklin, Barbara A.

AU - Kapler, Christine R.

AU - Tinley, Susan T.

AU - Liu, Bo

AU - Lerman, Caryn

PY - 1999/12/1

Y1 - 1999/12/1

N2 - Hereditary nonpolyposis colorectal carcinoma (HNPCC) is the most common hereditary form of colorectal carcinoma (CRC) and may account for 5-10% of the total CRC burden. The discovery of DNA mismatch repair (MMR) genes, inclusive of hMSH2, hMLH1, hPMS2, and hMSH6, has enabled the identification of who has and who does not have inordinately increased susceptibility to CRC as well as a litany of extracolonic cancers. Mutation testing has focused on hMSH2 and hMLH1, the most common mutations in HNPCC. The protocol for DNA testing and DNA-based genetic counseling is described in Part I of this study. One hundred ninety-nine bloodline relatives were tested and counseled from five hMLH1 and two hMSH2 families. Their major reason for seeking genetic counseling and DNA testing was to inform their children and other loved ones of their mutation status. Those who sought counseling overestimated their risk for inheriting the mutation and showed a high rate of interest in prophylactic surgery, and many were greatly concerned about insurance discrimination. Knowledge about HNPCC, its molecular genetic diagnosis, surveillance and management opportunities, and genetic counseling implications are still emerging, all in the face of a greater need for physician education regarding all facets of hereditary cancer.

AB - Hereditary nonpolyposis colorectal carcinoma (HNPCC) is the most common hereditary form of colorectal carcinoma (CRC) and may account for 5-10% of the total CRC burden. The discovery of DNA mismatch repair (MMR) genes, inclusive of hMSH2, hMLH1, hPMS2, and hMSH6, has enabled the identification of who has and who does not have inordinately increased susceptibility to CRC as well as a litany of extracolonic cancers. Mutation testing has focused on hMSH2 and hMLH1, the most common mutations in HNPCC. The protocol for DNA testing and DNA-based genetic counseling is described in Part I of this study. One hundred ninety-nine bloodline relatives were tested and counseled from five hMLH1 and two hMSH2 families. Their major reason for seeking genetic counseling and DNA testing was to inform their children and other loved ones of their mutation status. Those who sought counseling overestimated their risk for inheriting the mutation and showed a high rate of interest in prophylactic surgery, and many were greatly concerned about insurance discrimination. Knowledge about HNPCC, its molecular genetic diagnosis, surveillance and management opportunities, and genetic counseling implications are still emerging, all in the face of a greater need for physician education regarding all facets of hereditary cancer.

UR - http://www.scopus.com/inward/record.url?scp=17144439173&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17144439173&partnerID=8YFLogxK

M3 - Article

VL - 86

SP - 2457

EP - 2463

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 11 SUPPL.

ER -